Are you (or do you know) a post-doc/PhD/physician dedicated to #healthservicesresearch?
We're now accepting appli… https://t.co/zNye2GjXCD
Join us here @DeptPopMed today at noon as @CHeRP_DPM's Katherine Yih presents the next Brown Bag Seminar. Dr. Yih w… https://t.co/sFozU7f18L
Happening this morning at 10am! Stick around for a group discussion, 11am-12pm.
At the next @DeptPopMed Biostats S… https://t.co/4qmmoQOoSv
Welcome to our spotlight series, where we look beyond the CV and learn more about our investigators. Meet Hao Yu, PhD, a new faculty member studying the effects of large-scale state or national health policies on population and patient-centered measures.
Updated guidelines from the American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) for the treatment of hepatitis C now allow for a shorter 8-week treatment regimen for Black patients. These revised guidelines are based in part on a study led by Assistant Professor Julia Marcus and colleagues from Kaiser Permanente comparing the effectiveness of 8- and 12-week treatment regimens for the treatment of hepatitis C.